DCT Contract Funds To Be 20 Percent less In FY 1986 Than In 1985; To Eliminate ‘Low Priority’ Contracts
In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill
DCT Board Approves Phase 2/3 Studies Of LAK-IL-2
NCAB Approves Addition Of Two New Organ Systems
Clinical Education Program Phase Out Opposed By NCAB Committee
NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final









